In the BioHarmony Drug Report Database

"Preview" Icon

Ceftazidime

Ceftazidime Container, Ceptaz, Fortaz, Zavicefta (ceftazidime) is a small molecule pharmaceutical. Ceftazidime was first approved as Ceftazidime Container on 1985-07-19. It is used to treat acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, and bacterial skin diseases amongst others in the USA. It has been approved in Europe to treat bacterial pneumonia, gram-negative bacterial infections, pneumonia, soft tissue infections, and urinary tract infections.

 

Trade Name

 

Zavicefta
 

Common Name

 

ceftazidime
 

ChEMBL ID

 

CHEMBL44354
 

Indication

 

acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, bacterial skin diseases, escherichia coli infections, fever, gram-negative bacterial infections, haemophilus infections, infectious bone diseases, klebsiella infections, neutropenia, pneumonia, proteus infections, pseudomonas infections, sepsis, serratia infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections
 

Drug Class

 

Cephalosporins

Image (chem structure or protein)

Ceftazidime structure rendering